Epstein-Barr virus vectors for gene therapy

Advances in Virus Research

Volumn 55, Issue , 2000, Pages 453-462

  Komaki, Satoru ^a   Vos, Jean Michel H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; EPSTEIN BARR VIRUS; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PLASMID; REVIEW;

ANIMALS; GENE THERAPY; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; HUMANS; MICE; PLASMIDS;

EID: 0034571798     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/s0065-3527(00)55012-x     Document Type: Review

References (35)

1. A.L Kirchmaier B Sugden Plasmid maintenance of derivatives of oriP of Epstein-Barr virus J. Virol. 69 1995 1280 1283
2. D Reisman J Yates B Sugden A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis -acting components Mol. Cell. Biol. 5 1985 1822 1832
3. J.L Yates N Warren B Sugden Stable replication of plasmid derived from Epstein-Barr virus in various mammalian cells Nature 313 1985 812 815
4. L Frappier M O'Donnell EBNAl distorts ori P. Epstein-Barr virus latent replication origin J. Virol. 66 1992 1786 1790
5. J Hearing Y Mulhaupt S Harper Interaction Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication J. Virol. 66 1992 694 705
6. T.A Gahn C.L Schildkraut The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication Cell 58 1989 527 535
7. C.R Sclimenti M.P Calos Epstein-Barr vectors for gene expression and transfer Curr. Opin. Biotechnol. 9 1998 476 479
8. J.-M.H Vos Therapeutic mammalian artificial episomal chromosomes Curr. Opin. Mol. Ther. 1 1999 204 215
9. D.A Wysokenski J.L Yates Multiple EBNAl-binding sites are required to form an EBNAl-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus J. Virol. 63 1989 2657 2666
10. M Shirakata K Hirai Identification of minimal oriP of Epstein-Barr virus required for DNA replication J. Biochem. 123 1998 175 181
11. R.D Little C.L Schildkraut Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin Mol. Cell. Biol. 15 1995 2893 2903
12. L Lindenboim D Anderson R Stein The use of Epstein-Barr virusbased shuttle vectors in rat PC12 cells Cell. Mol. Neurobiol. 17 1997 119 127
13. Z.T Kelleher H Fu E Livanos B Wendelburg S Gulino J.-M.H Vos Epstein-Barr-based episomal chromosomes shuttle 100 kb of self-replicating circular human DNA in mouse cells Nat. Biotechnol. 16 1998 762 768
14. K Tomiyasu E Satoh Y Oda K Nishizaki M Kondo J Imanishi O Mazda Gene transfer in vitro and in vivo with Epstein-Barr virus-based episomal vector results in markedly high transient expression in rodent cells Biochem. Biophys. Res. Commun. 253 1998 733 738
15. A.L Kirchmaier B Sugden Rep: A viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus J. Virol. 72 1998 4657 4666
16. J.G Wohlgemuth S.H Kang G.H Bulboaca K.A Nawotka M.P Calos Long-term gene expression from autonomously replicating vectors in mammalian cells Gene Ther. 3 1996 503 512
17. P.J Krysan M.P Calos Epstein-Barr virus-based vectors that replicate in rodent cells Gene 136 1993 137 143
18. J.-M.H Vos The simplicity of complex MACS Nat. Biotechnol. 15 1997 1257 1259
19. T.-Q Sun D.A Fernstemacher J.-M.H Vos Human artificial episomal chromosomes for cloning large DNA fragments in human cells Nat. Genet. 8 1994 33 41
20. E.M Westphal H Sierakowska E Livanos R Kole J.M Vos A system for shuttling 200-kb BAC/PAC clones into human cells: Stable extrachromosomal persistence and long-term ectopic gene activation Hum. Gene Ther. 9 1998 1863 1873
21. H.J Delecluse T Hilsendegen D Pich R Zeidler W Hammerschmidt Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to humans 3rd Ed. Proc. Natl. Acad. Sci. U.S.A. 95 1998 8245 8250
22. R Wade-Martins J Frampton M.R James Long-term stability of large insert genomic DNA episomal shuttle Vectors in human cells Nucleic Acids Res. 27 1999 1674 1682
23. S Banerjee E Livanos J.-M.H Vos Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious EpsteinBarr virus Nat. Med. 1 1995 1303 1308
24. H.J Delecluse D Pich T Hilsendegen C Baum W Hammerschmidt A first-generation packaging cell line for Epstein-barr virus-derived vectors 3rd Ed. Proc. Natl. Acad. Sci. U.S.A. 96 1999 5188 5193
25. S Wang J.-M.H Vos An HSV/EBV base vectors for high efficient gene transfer to human cells in vitro / in vivo J. Virol. 70 1996 8422 8430
26. T Kinsella G Nolan Episomal vectors rapidly and stably produce high-titer recombinant retrovirus Hum. Gene Ther 7 1996 1405 1413
27. F Grignani T Kinsella A Mencarelli M Valtieri D Riganelli F Grignani L Lanfrancone C Peschle G.P Nolan P.G Pelicci High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein Cancer Res. 58 1998 14 19
28. F Langle-Rouault V Patzel A Benavente M Taillez N Silvestre A Bompard G Sczakiel E Jacobs K Rittner Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: Implications of the nuclear import of plasmids J. Virol. 72 1998 6181 6185
29. F Wang X Li B Annis D.L Faustman Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class 1 expression in type I diabetic cells Hum. Gene Ther. 6 1995 1005 1017
30. D.C Lei K Kunzelmann T Koslowsky M.J Yezzi L.C Escobar Z Xu A.R Ellison J.M Rommens L.-C Tsui M Tykocinski D.C Gruenert Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells Gene Ther. 3 1996 427 436
31. S Mucke A Polack M Pawlita D Zehnpfennig N Massoudi H Bohlen W Doerfler G Bornkamm V Diehl J Wolf Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells Gene Ther. 4 1997 82 92
32. H Hirai E Satoh M Osawa T Inaba C Shimazaki S Kinoshita M Nakagawa O Mazda J Imanishi Use of EBV-based Vector/IIVJ-liposome complex vector for targeted gene therapy of EBV associated neoplasms Biochem. Biophys. Res. Commun. 241 1997 112 118
33. H Junbo Q Li W Zaide H Yunde Receptor-mediated interleukin-2 gene transfer into human hepatoma cells Int. J. Mol. Med. 3 1999 601 608
34. Y Saeki M Wataya-Kaneda K Tanaka Y Kaneda Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes Gene Ther. 5 1998 1031 1037
35. J Komano M Sugiura K Takada Epstein-barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell J. Virol. 7 1998 9150 9156